283 related articles for article (PubMed ID: 9891042)
1. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes.
Adams PD; Li X; Sellers WR; Baker KB; Leng X; Harper JW; Taya Y; Kaelin WG
Mol Cell Biol; 1999 Feb; 19(2):1068-80. PubMed ID: 9891042
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
[TBL] [Abstract][Full Text] [Related]
3. Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A.
Zheleva DI; McInnes C; Gavine AL; Zhelev NZ; Fischer PM; Lane DP
J Pept Res; 2002 Nov; 60(5):257-70. PubMed ID: 12383116
[TBL] [Abstract][Full Text] [Related]
4. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
5. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.
Adams PD; Sellers WR; Sharma SK; Wu AD; Nalin CM; Kaelin WG
Mol Cell Biol; 1996 Dec; 16(12):6623-33. PubMed ID: 8943316
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.
Connell-Crowley L; Harper JW; Goodrich DW
Mol Biol Cell; 1997 Feb; 8(2):287-301. PubMed ID: 9190208
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.
Higashi H; Suzuki-Takahashi I; Saitoh S; Segawa K; Taya Y; Okuyama A; Nishimura S; Kitagawa M
Eur J Biochem; 1996 Apr; 237(2):460-7. PubMed ID: 8647086
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a regulatory motif that controls the exposure of specific upstream cyclin-dependent kinase sites that determine both conformation and growth suppressing activity of pRb.
Driscoll B; T'Ang A; Hu YH; Yan CL; Fu Y; Luo Y; Wu KJ; Wen S; Shi XH; Barsky L; Weinberg K; Murphree AL; Fung YK
J Biol Chem; 1999 Apr; 274(14):9463-71. PubMed ID: 10092628
[TBL] [Abstract][Full Text] [Related]
10. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
Lowe ED; Tews I; Cheng KY; Brown NR; Gul S; Noble ME; Gamblin SJ; Johnson LN
Biochemistry; 2002 Dec; 41(52):15625-34. PubMed ID: 12501191
[TBL] [Abstract][Full Text] [Related]
11. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545
[TBL] [Abstract][Full Text] [Related]
12. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
Horton LE; Templeton DJ
Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
[TBL] [Abstract][Full Text] [Related]
13. Physical interaction between pRb and cdk9/cyclinT2 complex.
Simone C; Bagella L; Bellan C; Giordano A
Oncogene; 2002 Jun; 21(26):4158-65. PubMed ID: 12037672
[TBL] [Abstract][Full Text] [Related]
14. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
15. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
Zhu L; Harlow E; Dynlacht BD
Genes Dev; 1995 Jul; 9(14):1740-52. PubMed ID: 7622038
[TBL] [Abstract][Full Text] [Related]
16. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
17. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
18. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
Lundberg AS; Weinberg RA
Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
[TBL] [Abstract][Full Text] [Related]
19. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
[TBL] [Abstract][Full Text] [Related]
20. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases.
Zarkowska T; Mittnacht S
J Biol Chem; 1997 May; 272(19):12738-46. PubMed ID: 9139732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
